Mesenchymal Cell News Volume 13.44 | Nov 9 2021

    0
    41







    2021-11-09 | MESCN 13.44


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 13.44 – 9 November, 2021
    TOP STORY

    Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection

    Among various cell sources, FGL1/PD-L1 small extracellular vesicles (sEVs) derived from MSCs not only enriched FGL1/PD-L1 expression but also maintained the immunomodulatory properties of unmodified MSC sEVs.
    [Advanced Science]

    Full Article

    Scientific resources to support your cancer research. Learn More!
    PUBLICATIONSRanked by the impact factor of the journal

    Macrophages Orchestrate the Expansion of a Proangiogenic Perivascular Niche during Cancer Progression

    Scientists demonstrated that Lyve-1+ tumor-associated macrophages supported tumor growth and identified a pivotal role for these cells in maintaining a population of perivascular mesenchymal cells that expressed α-smooth muscle actin and phenotypically resembled pericytes.
    [Science Advances]

    Full Article

    Self-Renewal or Quiescence? Orchestrating the Fate of Mesenchymal Stem Cells by Matrix Viscoelasticity via PI3K/Akt-CDK1 Pathway

    Researchers established an alginate hydrogel system with constant stiffness and tunable stress relaxation rate, which was a key parameter for the viscoelastic property of the material.
    [Biomaterials]

    Abstract

    High-Throughput On-Chip Human Mesenchymal Stromal Cell Potency Prediction

    Investigators presented a high-throughput, scalable, low-cost, on-chip microfluidic potency assay with improved functional predictive power and recapitulation of in vivo secretory responses compared to traditional approaches.
    [Advanced Healthcare Materials]

    Abstract

    Single-Cell RNA-Seq of Out-of-Thaw Mesenchymal Stromal Cells Shows Tissue-of-Origin Differences and Inter-Donor Cell-Cycle Variations

    The authors showed that donor differences in human MSC (hMSC) transcriptome were minor relative to the intrinsic differences in tissue-of-origin. hMSCs with different transcriptomic profiles showed potential differences in functional characteristics.
    [Stem Cell Research & Therapy]

    Full Article

    A Functional Extracellular Matrix Biomaterial Enriched with VEGFA and bFGF as Vehicle of Human Umbilical Cord Mesenchymal Stem Cells in Skin Wound Healing

    Scientists prepared a functional cell derived extracellular matrix biomaterial enriched with VEGFA and bFGF, which induced endothelial differentiation of human umbilical cord MSCs and promoted angiogenesis, which may improve the healing effect of skin injury.
    [Biomedical Materials]

    Abstract

    MicroRNA-200c/429 Mediated Regulation of Zeb1 Augments N-cadherin in Mouse Cardiac Mesenchymal Cells

    Researchers investigated the expression of N-Cadherin, a trans-membrane protein that enhanced the cell adhesion and recently gained attention for differentiation and augmentation of stem cell function, in mouse cardiac MSCs.
    [Cell Biology International]

    Abstract

    PPARβ/δ Accelerates Bone Regeneration in Diabetic Mellitus by Enhancing AMPK/mTOR Pathway-Mediated Autophagy

    Investigators explored the effects of PPARβ/δ agonist on the regeneration of diabetic bone defects and the osteogenic differentiation of rat bone marrow MSCs under a pathological high-glucose condition.
    [Stem Cell Research & Therapy]

    Full Article

    Sensitization of the UPR by Loss of PPP1R15A Promotes Fibrosis and Senescence in IPF

    The authors demonstrated the major role of PPP1R15A in the regulation of lung mesenchymal cells, and regulation of PPP1R15A may represent a novel therapeutic strategy in idiopathic pulmonary fibrosis.
    [Scientific Reports]

    Full Article

    Protective Effects of Low-Molecular-Weight Components of Adipose Stem Cell-Derived Conditioned Medium on Dry Eye Syndrome in Mice

    Researchers demonstrated the protective effects of low-molecular-weight adipose-derived stem cell-conditioned medium in a mouse model of dry eye syndrome.
    [Scientific Reports]

    Full Article

    Brain-Derived Neurotrophic Factor Promotes Immune Reconstitution Following Radiation Injury via Activation of Bone Marrow Mesenchymal Stem Cells

    Brain-derived neurotrophic factor promoted hematopoietic regeneration via activation of PDGFRα+ bone marrow MSCs which increased secretion of hematopoietic cytokines interleukin 6 and leukemia inhibitory factor in response to TrkB activation.
    [PLoS One]

    Full Article

    Impact of Insulin Producing Cells Derived from Adipose Tissue Mesenchymal Stem Cells on Testicular Dysfunction of Diabetic Rats

    Scientists investigated the effect of insulin-producing cells derived from adipose tissue MSCs on diabetic-induced impairments as the abnormalities of testicular tissues, oxidative stress of testes, and defects of spermatogenesis.
    [Heliyon]

    Full Article

    Stay up-to-date with the latest stem cell research by listening to the Stem Cell Podcast!
    REVIEWS

    Mesenchymal Stem Cells in Cancer Progression and Anticancer Therapeutic Resistance

    The authors analyze the existing researches and elaborate on the functions of MSCs in cancer progression and anticancer therapeutic resistance, demonstrating that MSCs may be a viable cancer therapeutic target.
    [Cancer Cell International]

    Full Article

    Advances in Mesenchymal Stem Cell Conditioned Medium-Mediated Periodontal Tissue Regeneration

    Investigators discuss the accumulating evidence indicating the therapeutic potential of the MSC-conditioned medium in periodontal regeneration-related pre-clinical and clinical studies.
    [Journal of Translational Medicine]

    Full Article

    INDUSTRY AND POLICY NEWS

    Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase I Dose Expansion Study of TP-1287 in Patients with Sarcoma

    Sumitomo Dainippon Pharma Oncology, Inc. announced that the first patient has been dosed in the Phase I dose expansion portion of the study evaluating the investigational agent TP-1287, an oral cyclin-dependent kinase 9 inhibitor, in patients with sarcoma.
    [Sumitomo Dainippon Pharma Oncology, Inc.]

    Press Release

    FEATURED EVENT

    Cell Bio Virtual 2021

    December 1 – 10, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Lecturer – Biomaterials and Tissue Engineering

    The University of Sheffield – Sheffield, England, United Kingdom

    Postdoctoral Scholar – Regenerative Medicine

    University of Southern California School of Dentistry – Los Angeles, California, United States

    Postdoctoral Fellowship – Musculoskeletal Tissue Injury

    The University of Texas Southwestern Medical Center – Dallas, Texas, United States

    Postdoctoral Research Fellow – Tumor Microenvironment

    Fred Hutchinson Cancer Research Center – Seattle, Washington, United States

    Postdoctoral Research Fellow – iPSC Reprogramming

    Northwestern University – Chicago, Illinois, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter